[163] There was low- to moderate-strength evidence of no benefit for most of the other medications used in RCTs, which included antidepressants (bupropion, mirtazapine, sertraline), antipsychotics (aripiprazole), anticonvulsants (topiramate, baclofen, gabapentin), naltrexone, varenicline, citicoline, ondansetron, prometa, riluzole, atomoxetine, dextroamphetamine, and modafinil
We do not take that trust lightly and look forward to leveraging our expertise and commitment to the best patient care for your child's health.
Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer
Kick your waistline into better shape by giving your body the support it needs
long-term discontinuation data are still emerging from Phase 3 TRIUMPH trials